Prue Ursala

Mounjaro Shortage June 2025. Mounjaro (tirzepatide) is a diabetes medication with weight loss as a side effect. Some patients fear tirzepatide, sold by eli lilly under the brand names zepbound and mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing.

What we are doing about the mounjaro vial shortage. The next day, the food and drug administration updated the status of mounjaro and zepbound in its drug shortage database to indicate they are available once more.